Short-term use of the lowest effective dose of hormone therapy for menopausal symptoms is unlikely to cause breast cancer. — Whalespan
Short-term use of the lowest effective dose of hormone therapy for menopausal symptoms is unlikely to cause breast cancer.
⚠ High risk
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
◐PARTIALLYSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
“using hormones for a period of time the lowest dose that treats the symptoms the most effectively is not going to give you breast cancer most likely I can't promise that you won't get breast cancer because one in eight or nine women get it anyway and you might be genetic more likely but not from a shortterm use of the lowest dose possible to suppress your symptoms”